1-10 of 10
Ana Maria Avila
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility and Target AUC Accuracy of Personalized High Dose Melphalan in Myeloma

Karen Sweiss, Kyeongmin Kim, Yizhen Guo, Kasey Hill, Nicole Abbott, Matias Eugenio Sanchez, Chukwuemeka Uzoka, Ana Maria Avila Rodriguez, John G Quigley, Nadim Mahmud, Damiano Rondelli, Douglas W Sborov, Donald Harvey, Ajay K. Nooka, Madhav V. Dhodapkar, Jonathan L. Kaufman, Nisha S. Joseph, Sagar Lonial, Pritesh Patel, Mitch A. Phelps, Craig C. Hofmeister
Journal: Blood
Blood (2024) 144 (Supplement 1): 1993.
https://doi.org/10.1182/blood-2024-205614
Published: 2024
Journal Articles

Real-World Outcomes of Monoclonal Gammopathy of Renal Significance (MGRS) in the Era of Novel Therapies

Francesca Cottini, Ana Maria Avila Rodriguez, Karen Sweiss, Chukwuemeka Uzoka, Zhengjia Chen, Weiwei Ma, Elvira Umyarova, Anjali Satoskar, Pierre Rodriguez, Matias Sanchez
Journal: Blood
Blood (2024) 144 (Supplement 1): 3298.
https://doi.org/10.1182/blood-2024-198929
Published: 2024
Journal Articles

Free from Drug Therapy in Multiple Myeloma (FREEDMM): MRD-Based Cessation of Maintenance

Ana Maria Avila Rodriguez, Danny Hadidi, Craig C. Hofmeister, John Quigley, Maria Zappia, Maxim Frolov, Elizaveta Benevolenskaya, Matias Eugenio Sanchez, Shrihari Kadkol, Douglas Sborov, Damiano Rondelli, Chukwuemeka Uzoka, Karen Sweiss
Journal: Blood
Blood (2023) 142 (Supplement 1): 3395.
https://doi.org/10.1182/blood-2023-190011
Published: 2023
Journal Articles

Individual-Level Social Determinants of Health (SDOH) Measures and Treatment Complications in Acute Leukemia

Eshana Shah, Ana Maria Avila Rodriguez, Jerry W Luo, Joanna Cwykiel, Tasha Chasson, Elizabeth Raigoza, Alexander Bratslavsky, Peter Doukas, Reanna Williams, Christa Jackowicz, Hyein Lee, Talha Khan, Kimberly Webb, Yasmin Abaza, Jessica K. Altman, Betina Yanez, John Quigley, Carlos Galvez, Shira N. Dinner, Kim Johnson, Madelyn Burkart, Irum Khan
Journal: Blood
Blood (2023) 142 (Supplement 1): 374.
https://doi.org/10.1182/blood-2023-189024
Published: 2023
Journal Articles

Addition of Myeloablative Doses of Total Marrow Irradiation (TMI) to Myeloablative Fludarabine/Busulfan Conditioning for Allogeneic HSCT in Patients with High-Risk AML, CML, or Myelodysplastic Syndrome: A Phase II Clinical Trial

Lucas Maahs, Matthew Koshy, Karen Sweiss, Kang-hyun Ahn, Zhengjia Chen, Chukwuemeka Uzoka, Carlos Galvez, Paul Rubinstein, John Quigley, Santosh L. Saraf, Ana Maria Avila Rodriguez, Bulent Aydogan, Nadim Mahmud, Damiano Rondelli
Journal: Blood
Blood (2023) 142 (Supplement 1): 4897.
https://doi.org/10.1182/blood-2023-179270
Published: 2023
Journal Articles

Chronic Opioid Use Is Highly Prevalent and Associated with Inferior Survival in Myeloma Patients in Remission after Autologous Transplant

Karen Sweiss, Craig C Hofmeister, John G. Quigley, Jaleel G. Sweis, Kaily Kurzweil, Douglas W. Sborov, Lisa Sharp, Gregory S Calip, Lucas Maahs, Ana Maria Avila, Chukwuemeka Uzoka, Elizabeth Ilo, Elliot Wolf, Damiano Rondelli, Pritesh Patel
Journal: Blood
Blood (2022) 140 (Supplement 1): 5252–5253.
https://doi.org/10.1182/blood-2022-171045
Published: 2022
Journal Articles

A Phase Ib Study of the Safety and Efficacy of Venetoclax When Combined with Escalating Doses of Omacetaxine in Patients with Relapsed/Refractory Acute Myeloid Leukemia Failing Treatment with Venetoclax-Containing Regimens (VEN-OM)

Ana Maria Avila, Saad Arain, Karen Sweiss, Pritesh Patel, Samin Houshyar, Gregory S Calip, Irum Khan, Paul G. Rubinstein, Chukwuemeka Uzoka, John G. Quigley
Journal: Blood
Blood (2022) 140 (Supplement 1): 11774–11775.
https://doi.org/10.1182/blood-2022-165565
Published: 2022
Journal Articles

A Mixed Methods Study to Examine the Influence of Structural Racism on Treatment in Acute Myeloid Leukemia

Eshana Shah, Ana Maria Avila, Jerry W Luo, Tasha Chasson, Elizabeth Raigoza, Ana Gordon, Michael Berbaum, Agatha Gallo, Irum Khan
Journal: Blood
Blood (2022) 140 (Supplement 1): 5262–5263.
https://doi.org/10.1182/blood-2022-159727
Published: 2022
Journal Articles

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Saad Arain, Ana Maria Avila, Sonia Christian, Pritesh Patel, Karen Sweiss, Brian Parkin, Santosh L. Saraf, Paul G. Rubinstein, Gregory S Calip, John G. Quigley
Journal: Blood
Blood (2022) 140 (Supplement 1): 11725–11726.
https://doi.org/10.1182/blood-2022-165615
Published: 2022
Journal Articles

Long-Term Adverse Events of Total Marrow Irradiation (TMI)-Based Conditioning Chemotherapy in Hematopoietic Stem Cell Transplant Recipients Treated on a Phase I/II Trial

Lucas Maahs, Pritesh Patel, Karen Sweiss, Chukwuemeka Uzoka, Nadim Mahmud, Ana Maria Avila, Matthew Koshy, Damiano Rondelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 12913–12914.
https://doi.org/10.1182/blood-2022-163424
Published: 2022